Manufacturing / Pharmaceutical Preparations
BioAge Labs, Inc.
BIOA
$6.33
+$0.11 (+1.84%)
Price as of Oct 9, 2026 16:19 UTC
420 M
Market Cap (Small Cap)
20%
IV Rank
146.2%
Implied Volatility
Nov 04
Next Earnings
Technical Signals
as of Oct 7
Bearish
0 of 7
Trend
- Above 20-day average $7.56
- Above 50-day average $10.18
- Above 200-day average $13.45 · -53.5%
- Moving averages stacked Not aligned
Momentum
- Golden cross (50/200) Down · 27d ago
- Momentum cross (20/50) Down · 46d ago
Volume
- Below-average volume 0.9x avg
Price & Trend
Daily candles with EMA 20, SMA 50. Drag to zoom.
Options Activity & Greeks
Implied volatility, flow, and dealer positioning from the options market.
Put/Call Ratio
0.01
Bullish skew
Implied Volatility
146.2%
1% percentile
IV vs Realized
Options rich
30d HV 61.2%
Options Heat Map
Delta-risk grid for BIOA options across strikes and expirations. Hover any cell for full Greeks.
Loading option chain data...
Insider Trades
0 buys
13 sells
| Date | Insider | Title | Type | Shares | Value | Since Trade |
|---|---|---|---|---|---|---|
| Jun 30, 2026 | Barton Shane | Sell | 20,216 | $509,176 | -75.3% | |
| Jun 30, 2026 | Barton Shane | Exercise | 4,290 | $0 | -74.7% | |
| Jun 30, 2026 | Barton Shane | Exercise | 7,861 | $34,431 | +41.8% | |
| Jun 30, 2026 | Barton Shane | Exercise | 4,065 | $17,480 | +44.4% | |
| Jun 30, 2026 | Barton Shane | Exercise | 7,861 | $0 | -74.7% | |
| Jun 30, 2026 | Barton Shane | Exercise | 4,065 | $0 | -74.7% | |
| Jun 30, 2026 | Barton Shane | Exercise | 4,000 | $0 | -74.7% | |
| Jun 30, 2026 | Barton Shane | Exercise | 4,000 | $33,560 | -26.0% | |
| Jun 30, 2026 | Barton Shane | Exercise | 4,290 | $46,547 | -42.8% | |
| Jun 29, 2026 | Barton Shane | Exercise | 14,198 | $62,187 | +41.8% |
Earnings History
| Date | Quarter | EPS Est. | EPS Actual | Surprise | Result |
|---|---|---|---|---|---|
| Aug 12, 2026 | Q2 2026 | -$0.62 | |||
| Aug 04, 2026 | Q2 2026 | -$0.62 |
Track BIOA with ThetaPal
Get insider trade alerts, AI portfolio analysis, and options roll recommendations for BIOA and your entire portfolio.